Proteases as Targets for Therapy: Handbook of Experimental Pharmacology, cartea 140
Editat de Klaus, von der Helm, Bruce D. Korant, John C. Cheronisen Limba Engleză Paperback – 10 oct 2012
Din seria Handbook of Experimental Pharmacology
- 5% Preț: 1424.98 lei
- 5% Preț: 907.38 lei
- 5% Preț: 3446.28 lei
- 5% Preț: 730.28 lei
- 5% Preț: 1397.04 lei
- 5% Preț: 1406.17 lei
- 5% Preț: 1401.51 lei
- 5% Preț: 1891.48 lei
- 5% Preț: 1883.44 lei
- 5% Preț: 1898.12 lei
- 5% Preț: 2074.57 lei
- 5% Preț: 2076.90 lei
- 5% Preț: 2074.36 lei
- 5% Preț: 1088.10 lei
- 5% Preț: 1076.01 lei
- 5% Preț: 1391.47 lei
- 5% Preț: 1082.46 lei
- 5% Preț: 1082.46 lei
- 5% Preț: 1085.70 lei
- 5% Preț: 1084.27 lei
- 5% Preț: 1083.37 lei
- 5% Preț: 1150.54 lei
- 5% Preț: 400.28 lei
- 5% Preț: 401.38 lei
- 5% Preț: 539.88 lei
- 5% Preț: 705.92 lei
- 5% Preț: 718.27 lei
- 5% Preț: 716.49 lei
- 5% Preț: 731.34 lei
- 5% Preț: 732.60 lei
- 5% Preț: 710.56 lei
- 5% Preț: 727.78 lei
- 5% Preț: 385.33 lei
- 5% Preț: 720.79 lei
- 5% Preț: 713.60 lei
- 5% Preț: 381.69 lei
- 5% Preț: 715.93 lei
- 5% Preț: 725.61 lei
- 5% Preț: 715.42 lei
- 5% Preț: 708.78 lei
- 5% Preț: 716.49 lei
- 5% Preț: 711.98 lei
- 5% Preț: 3445.03 lei
- 5% Preț: 714.51 lei
- 5% Preț: 722.21 lei
- 5% Preț: 716.13 lei
- 5% Preț: 723.83 lei
- 5% Preț: 891.51 lei
- 5% Preț: 705.54 lei
Preț: 369.01 lei
Preț vechi: 388.44 lei
-5% Nou
Puncte Express: 554
Preț estimativ în valută:
70.61€ • 74.29$ • 58.46£
70.61€ • 74.29$ • 58.46£
Carte tipărită la comandă
Livrare economică 14-28 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642630231
ISBN-10: 3642630235
Pagini: 440
Ilustrații: XXVIII, 410 p. 80 illus., 13 illus. in color.
Dimensiuni: 155 x 235 x 23 mm
Greutate: 0.61 kg
Ediția:Softcover reprint of the original 1st ed. 2000
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642630235
Pagini: 440
Ilustrații: XXVIII, 410 p. 80 illus., 13 illus. in color.
Dimensiuni: 155 x 235 x 23 mm
Greutate: 0.61 kg
Ediția:Softcover reprint of the original 1st ed. 2000
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Section I. Human Immunodeficiency Virus Protease Inhibitors.- 1 The Road to Fortovase. A History of Saquinavir, the First Human Immunodeficiency Virus Protease Inhibitor.- 2 Clinical Experience with Human Immunodeficiency Virus Protease Inhibitors: Antiretroviral Results, Questions and Future Strategies.- 3 The Nature of Resistance to Human Immunodeficiency Virus Type-1 Protease Inhibitors.- 4 The Next Generation of Human Immunodeficiency Virus Protease Inhibitors: Targeting Viral Resistance.- Section II. Other Viral (Non-HIV) Protease Inhibitors.- 5 The Proteinases Encoded by Hepatitis C Virus as Therapeutic Targets.- 6 The Human Herpes-Virus Proteases.- 7 The 3C Proteinases of Picornaviruses and Other Positive-Sense, Single-Stranded RNA Viruses.- 8 Adenovirus Proteinase-Antiviral Target for Triple-Combination Therapy on a Single Enzyme: Potential Inhibitor-Binding Sites.- 9 Proteinases as Virulence Factors in Bacterial Diseases and as Potential Targets for Therapeutic Intervention with Proteinase Inhibitors.- 10 Parasite Proteases as Targets for Therapy.- Section III. (Non-Viral) Proteases Involved in Diseases.- 11 Host Proteinases as Targets for Therapeutic Intervention.- 12 The Role of Metalloprotease Inhibitors in Cancer and Chronic Inflammatory Diseases.- 13 The Tumor Necrosis Factor-? Converting Enzyme.- 14 Serine Elastases in Inflammatory and Vascular Diseases.- 15 Inhibitors of Thrombin and Factor Xa.- 16 Inhibitors of Papain-Like Cysteine Peptidases in Cancer.- 17 Caspases and Their Natural Inhibitors as Therapeutic Targets for Regulating Apoptosis.- 18 Proteasome and Apoptosis.- 19 Proteolytic Processing of the Amyloid Precursor Protein of Alzheimer’s Disease.- 20 Presenilins and ?-Amyloid Precursor Protein-Proteolytically Processed Proteins Involved inthe Generation of Alzheimer’s Amyloid ? Peptide.